Betta Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Betta Pharmaceuticals is reported as 2.4562 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0 Yuan Renminbi per share in 2023, which was 0 higher than 2020. And about -0.18178 billion Yuan Renminbi are reported as free cash flow in the financials of Betta Pharmaceuticals 2023. Dividends of 0.17 Yuan Renminbi per share were paid to shareholders of Betta Pharmaceuticals stock SZSE:300558 in fiscal 2023.

Forecast

Financials

Year	Year	TTM	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	¥2.25B	¥1.87B	¥1.55B	¥1.22B	¥1.03B	¥1.04B	¥0.00M
GM %	Gross Margin %	86.51%	92.23%	92.57%	93.23%	94.36%	95.74%	96.83%	0.00%
OM	Operating Margin	12.10%	15.53%	22.22%	18.38%	13.57%	22.72%	35.01%	0.00%
EPS	Earnings Per Share	¥0.83	¥0.83	¥0.83	¥0.52	¥0.35	¥0.50	¥1.01	¥0.85
Div.	Dividends	N/A	¥0.25	¥0.31	¥0.19	¥0.11	¥0.15	¥0.18	¥0.00
PR %	Payout Ratio %	0	30.12%	37.35%	36.54%	31.43%	30.00%	17.82%	0
Sha.	Shares	N/AM	415.39M	413.16M	401M	401M	401M	401M	360M
OCF	Operating Cash Flow	N/A	¥526.63M	¥646.02M	¥555.07M	¥286.40M	¥278.26M	¥407.05M	¥0.00M
FCF	Free Cash Flow	N/A	¥-,231.75M	¥-38.26M	¥-65.35M	¥-,328.30M	¥-,307.33M	¥112.55M	¥0.00M
FCFS	Free Cash Flow Per Share	¥-0.72	¥-0.56	¥-0.10	¥-0.16	¥-0.83	¥-0.76	¥0.31	¥0.00

Betta Pharmaceuticals financials at a glance

Financials

Discover